The enhanceosome

Current Opinion in Structural Biology

Volumn 18, Issue 2, 2008, Pages 236-242

  Panne, Daniel ^a  

^a EUROPEAN MOLECULAR BIOLOGY LABORATORY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 2; BETA INTERFERON; DNA (APURINIC OR APYRIMIDINIC SITE) LYASE; ENHANCEOSOME; HIGH MOBILITY GROUP A1A PROTEIN; HISTONE ACETYLTRANSFERASE PCAF; INTERFERON REGULATORY FACTOR 3; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR;

BINDING SITE; CONFORMATION; CRYSTAL STRUCTURE; DNA SEQUENCE; DNA STRUCTURE; EUKARYOTE; GENOME; MAMMAL; MOLECULAR EVOLUTION; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN PROTEIN INTERACTION; REVIEW;

ANIMALS; BASE SEQUENCE; ENHANCER ELEMENTS (GENETICS); INTERFERON-BETA; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; TRANSCRIPTION FACTORS;

EUKARYOTA; MAMMALIA;

EID: 41949113742     PISSN: 0959440X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sbi.2007.12.002     Document Type: Review

References (31)

1. Maniatis T., Falvo J.V., Kim T.H., Kim T.K., Lin C.H., Parekh B.S., and Wathelet M.G. Structure and function of the interferon-β enhanceosome. Cold Spring Harb Symp Quant Biol 63 (1998) 609-620. Comprehensive review of the earlier work on the interferon-β enhanceosome.
2. Agalioti T., Lomvardas S., Parekh B., Yie J., Maniatis T., and Thanos D. Ordered recruitment of chromatin modifying and general transcription factors to the IFN-beta promoter. Cell 103 (2000) 667-678. In this work, the authors show that the INF-β enhancer is nucleosome-free and that activation after virus infection leads to recruitment of GCN5, CBP/p300 and PolII, SWI/SNF and TFIID to the promoter.
3. Falvo J.V., Parekh B.S., Lin C.H., Fraenkel E., and Maniatis T. Assembly of a functional beta interferon enhanceosome is dependent on ATF-2/c-Jun heterodimer orientation. Mol Cell Biol 20 (2000) 4814-4825
4. Panne D., Maniatis T., and Harrison S.C. Crystal structure of ATF-2/c-Jun and IRF-3 bound to the interferon-beta enhancer. EMBO J 23 (2004) 4384-4393. Crystallographic, biochemical, and mutational analyses are combined to analyze the ATF-2/c-Jun and IRF-3 binding and complex formation on the INF-β enhancer. Cooperative binding occurs because the DNA-binding sites overlap and the DNA conformations are complementary.
5. Escalante C.R., Nistal-Villan E., Shen L., Garcia-Sastre A., and Aggarwal A.K. Structure of IRF-3 bound to the PRDIII-I regulatory element of the human interferon-beta enhancer. Mol Cell 26 (2007) 703-716. Crystallographic analysis of IRF-3 DNA-binding domains in complex with the PRDIII-I region of the human IFN-β enhancer. In vivo analysis shows that mutations in any IRF-binding site abolish transcription of the enhancer.
6. Panne D., Maniatis T., and Harrison S.C. An atomic model of the interferon-beta enhanceosome. Cell 129 (2007) 1111-1123. Determination of the crystal structure of NFκB, IRF-7, and IRF-3 bound to the enhancer sequence and of four IRF-3 DNA-binding domains bound to the enhancer. Together with a previously determined structure this work leads to a complete atomic model of the fully assembled enhanceosome. The role of the essential enhanceosome components IRF-3 and IRF-7 is addressed.
7. Du W., and Maniatis T. An ATF/CREB binding site is required for virus induction of the human interferon-β gene. Proc Natl Acad Sci U S A 89 (1992) 2150-2154
8. Marie I., Durbin J.E., and Levy D.E. Differential viral induction of distinct interferon-alpha genes by positive feedback through interferon regulatory factor-7. EMBO J 17 (1998) 6660-6669
9. Sato M., Hata N., Asagiri M., Nakaya T., Taniguchi T., and Tanaka N. Positive feedback regulation of type I IFN genes by the IFN-inducible transcription factor IRF-7. FEBS Lett 441 (1998) 106-110
10. Honda K., Yanai H., Negishi H., Asagiri M., Sato M., Mizutani T., Shimada N., Ohba Y., Takaoka A., Yoshida N., et al. IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature 434 (2005) 772-777. The authors show using knock-out mice that IRF-7 is essential for type I interferon production. Absence of IRF-7 alone or combined absence of IRF-3 and IRF-7 prevents induction of INF-β or INF-α.
11. Lin R., Genin P., Mamane Y., and Hiscott J. Selective DNA binding and association with the CREB binding protein coactivator contribute to differential activation of alpha/beta interferon genes by interferon regulatory factors 3 and 7. Mol Cell Biol 20 (2000) 6342-6353
12. Morin P., Braganca J., Bandu M.T., Lin R., Hiscott J., Doly J., and Civas A. Preferential binding sites for interferon regulatory factors 3 and 7 involved in interferon-A gene transcription. J Mol Biol 316 (2002) 1009-1022
13. Lin R., Heylbroeck C., Pitha P.M., and Hiscott J. Virus-dependent phosphorylation of the IRF-3 transcription factor regulates nuclear translocation, transactivation potential, and proteasome-mediated degradation. Mol Cell Biol 18 (1998) 2986-2996
14. Panne D., McWhirter S.M., Maniatis T., and Harrison S.C. Interferon regulatory factor 3 is regulated by a dual phosphorylation-dependent switch. J Biol Chem 282 (2007) 22816-22822
15. Qin B.Y., Liu C., Lam S.S., Srinath H., Delston R., Correia J.J., Derynck R., and Lin K. Crystal structure of IRF-3 reveals mechanism of autoinhibition and virus-induced phosphoactivation. Nat Struct Biol 10 (2003) 913-921
16. Escalante C.R., Shen L., Thanos D., and Aggarwal A.K. Structure of NFκB p50/p65 heterodimer bound to the PRDII DNA element from the interferon-beta promoter. Structure 10 (2002) 383-391
17. Ghosh G., van Duyne G., Ghosh S., and Sigler P.B. Structure of NFκB p50 homodimer bound to a kappa B site. Nature 373 (1995) 303-310
18. Muller C.W., Rey F.A., Sodeoka M., Verdine G.L., and Harrison S.C. Structure of the NFκB p50 homodimer bound to DNA. Nature 373 (1995) 311-317
19. Chen F.E., Huang D.B., Chen Y.Q., and Ghosh G. Crystal structure of p50/p65 heterodimer of transcription factor NFκB bound to DNA. Nature 391 (1998) 410-413
20. Chen-Park F.E., Huang D.B., Noro B., Thanos D., and Ghosh G. The kappa B DNA sequence from the HIV long terminal repeat functions as an allosteric regulator of HIV transcription. J Biol Chem 277 (2002) 24701-24708
21. Leung T.H., Hoffmann A., and Baltimore D. One nucleotide in a kappaB site can determine cofactor specificity for NFκB dimers. Cell 118 (2004) 453-464
22. Yie J., Liang S., Merika M., and Thanos D. Intra- and intermolecular cooperative binding of high-mobility-group protein I(Y) to the beta-interferon promoter. Mol Cell Biol 17 (1997) 3649-3662
23. Thanos D., Du W., and Maniatis T. The high mobility group protein HMG I(Y) is an essential structural component of a virus-inducible enhancer complex. Cold Spring Harb Symp Quant Biol 58 (1993) 73-81
24. Falvo J.V., Thanos D., and Maniatis T. Reversal of intrinsic DNA bends in the IFN beta gene enhancer by transcription factors and the architectural protein HMG I(Y). Cell 83 (1995) 1101-1111
25. Agresti A., and Bianchi M.E. HMGB proteins and gene expression. Curr Opin Genet Dev 13 (2003) 170-178
26. Merika M., Williams A.J., Chen G., Collins T., and Thanos D. Recruitment of CBP/p300 by the IFN beta enhanceosome is required for synergistic activation of transcription. Mol Cell 1 (1998) 277-287
27. Wathelet M.G., Lin C.H., Parekh B.S., Ronco L.V., Howley P.M., and Maniatis T. Virus infection induces the assembly of coordinately activated transcription factors on the IFN-beta enhancer in vivo. Mol Cell 1 (1998) 507-518
28. Yie J., Merika M., Munshi N., Chen G., and Thanos D. The role of HMG I(Y) in the assembly and function of the IFN-beta enhanceosome. EMBO J 18 (1999) 3074-3089
29. Munshi N., Agalioti T., Lomvardas S., Merika M., Chen G., and Thanos D. Coordination of a transcriptional switch by HMGI(Y) acetylation. Science 293 (2001) 1133-1136
30. Metivier R., Penot G., Hubner M.R., Reid G., Brand H., Kos M., and Gannon F. Estrogen receptor-alpha directs ordered, cyclical, and combinatorial recruitment of cofactors on a natural target promoter. Cell 115 (2003) 751-763. Comprehensive study of the timing of transcription factor association with the estrogen receptor-inducible pS2 promoter. The Authors show, using sequential ChIP that estrogen-induced transcription is a cyclical process and transcription factors are recruited in defined phases.
31. Bosisio D., Marazzi I., Agresti A., Shimizu N., Bianchi M.E., and Natoli G. A hyper-dynamic equilibrium between promoter-bound and nucleoplasmic dimers controls NFκB-dependent gene activity. EMBO J 25 (2006) 798-810